Market Overview

Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week

Share:
Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week

Cannabis Countdown: Top 10 Marijuana Stock News Stories of the Week

Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 marijuana stock news stories for the week of October 28th – November 3rd, 2019.

Without further ado, let’s get started.

10. CFN Media Interviews Red White & Bloom CEO Brad Rogers at Benzinga Chicago

Brad Rogers, CEO of Super-State Operator Red White & Bloom Goes In-Depth with Greg Hasty of CannabisFN

CFN Media, one of the largest cannabis-focused financial networks just published an interview with Red White & Bloom (CSE: RWB – IPO Soon) CEO Brad Rogers. The video interview was filmed on-site at the Benzinga Cannabis Capital Conference in Chicago last week.

Topics covered in the interview included: How the RWB story began, RWB’s colossal 3.6 million sq ft indoor CBD cultivation facilityMichigan and Illinois revenue projections, the nationwide CBD opportunity via huge retailers such as Walmart Inc (NYSE: WMT), Target Corporation (NYSE: TGT), CVS (NYSE: CVS) and Walgreens (NASDAQ: WBA) and the true meaning of the term “Super-State Operator” plus much more.

WATCH THE FULL CFN RWB CEO INTERVIEW

BONUS: WATCH RWB 10X CAPITAL INTERVIEW

9. 3 Time Super Bowl Champ Rob Gronkowski Teams Up With Abacus Health to Promote CBDMEDIC

Gronkowski Ready to ‘Gronk Spike’ CBD Market With New CBDMEDIC Business Deal

Multiple injuries and first-hand experience with Abacus Health Products (CSE: ABCS) (OTCQX: ABAHF) CEO convinced Gronk to hop on the CBD bandwagon.

READ FULL GRONK ARTICLE

8. ‘Fickle, Ignorant’ Canadian Retail Investors Getting Blamed for Cratering Cannabis Stocks

The Trajectory of Pot Stocks Could Change Dramatically When Institutional Investors Begin to Buy-in

With large institutions still reluctant to invest in pot, Canadian retail investors continue to dominate the public floats of many cannabis stocks, especially those based in the U.S. For example, institutions hold less than 1% of the float of Curaleaf (CSE: CURA) (OTCQX: CURLF), 1% of Cresco Labs (CSE: CL) (OTCQX: CRLBF) and 3% of Green Thumb (CSE: GTII) (OTCQX: GTBIF).

READ FULL RETAIL INVESTORS ARTICLE

7. MedMen Doubles Revenue While EBITDA Loss Triples, MMEN Shares Tumbles as Ludicrous Spending Continues

Following Poor Q4 Earnings, MedMen Amends $250 Million Gotham Green Credit Facility

MedMen (CSE: MMEN) (OTCQX: MMNFF) released its Q4 earnings yesterday after the closing bell and the “Apple Store of Weed” disappointed investors once again. MedMen reported revenue of $42 million for the fourth quarter, an increase of 104% year-over-year. However, MedMen’s adjusted EBITDA loss for the full-year was more than triple 2018’s.

READ FULL MEDMEN ARTICLE

6. All Dried Up: How Bay Street Cashed in on the Cannabis Frenzy Before the Carnage

The Warning Signs Were There All Summer, But it Wasn’t Until the First of September That the Day of Reckoning Arrived

After markets closed on September 3rd, Aurora Cannabis (TSX: ACB) (NYSE: ACB) tried to sell its 10.5% stake in The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF) to public investors.

The industry’s original financial backers have now largely moved on to more promising U.S.-based companies, or are out of the sector altogether. Retail investors, meanwhile, are still heavily invested, holding 80% or more of many cannabis companies’ shares.

READ FULL BAY STREET ARTICLE

5. Hexo Corp. Reports Fourth Quarter Earnings

HEXO Posts Revenue of $15.4 Million, Loss of $56.7 Million

Hexo Corp. (TSX HEXO) (NYSE: HEXO) released its financial results for the fourth quarter of 2019, recognizing net revenues of $15.39 million during the quarter while posting a total net loss of $56.68 million.

READ FULL HEXO EARNINGS ARTICLE

4. Canopy Growth Reveals New Cannabis Drinks and Edibles

Canopy Also Introduced 2 THC Infused Beverages Under its Seth Rogen Backed Houseplant Brand

Canopy Growth (TSX: WEED) (NYSE: CGC) has rolled out its first batch of cannabis drinks and chocolates, with products ranging from psychoactive ginger ale, to a CBD-infused cucumber and mint sparkling water, to “Bean & Bud” cacao medallions.

READ FULL CANOPY GROWTH ARTICLE

3. HEXO Secures Cannabis 2.0 Licences From Health Canada, Flow Glow CBD Drink Set to Hit Shelves Soon

HEXO’s New Licences Allow for the Sale of Cannabis Edibles, Beverages, Extracts and Topicals

HEXO Corp. (TSX: HEXO) (NYSE: HEXO) and JV partner Molson Coors (NYSE: TAP) are set to release their new Flow Glow CBD beverage this December.

READ FULL HEXO ARTICLE

2. Forget Canada, Cannabis 2.0 is Really the Birth of the U.S. Market

Is a Diverse Canadian Market Really Cannabis 2.0? Or is it the Enormous Opportunity South of the Border?

Canadian cannabis stocks all face headwinds and yet they trade for heavy multiples, as shown by the comparison charts below. These prices are not justified until the true prize in the North American market comes into play–and that is the United States.

  • AltaCorp’s Canadian pot stock recommendations and price targets.
  • TCI’s current U.S. MSO watchlist.

READ FULL CANNABIS 2.0 ARTICLE

1. Liberty Health Posts Strong Q2 Earnings, Net Revenue Soars 379%

Liberty Health Sees Q2 Net Revenue Surge to $10.63 Million, LHS Stock Jumps 20% in Response to Stellar Earnings

Liberty Health (CSE: LHS) (OTCQX: LHSIF) released its earnings this morning for the second quarter ended August 31, 2019. The company saw its consolidated net revenue for the quarter jump 378.88% year over year.

READ FULL LIBERTY HEALTH ARTICLE

Image Sourced from Pixabay

Posted-In: cannabis industry CBD HempCannabis Earnings News Markets General

 

Related Articles (ACB + ABAHF)

View Comments and Join the Discussion!

Bausch Analyst Sees Challenging Setup For Next Leg Of Recovery Story

Mid-Morning Market Update: Markets Open Higher; Sysco Reports Mixed Q1 Results